In The Media
They talk about us.
New Paper just published on non-invasive extraction of hemodynamic variables in rats
We’re thrilled to share our latest paper demonstrating the feasibility of completely non-invasive evaluation of inotrope effects! Seeing progress in stroke volume and cardiac output monitoring since my PhD is truly rewarding says Timothé FLENET, CEO and Scientific...
Etisense and Bioseb announce distribution partnership for DECRO® wearable telemetry solution in Europe and North America
ETISENSE continues to expand access to its solutions internationallyLyon & Vitrolles, France – June 2025 — Etisense, a French biomedical engineering company specializing in wearable telemetry for preclinical research, is proud to announce a new partnership...
Etisense and Marshall BioResources Europe join forces to rethink research practices
Etisense and Marshall BioResources Europe Collaborate to Develop an Innovative Telemetric Jacket for Beagle DogsLyon, France – 06 May, 2025 – Etisense, a French biomedical engineering company specializing in wearable telemetry for preclinical research, is proud to...
NHPig EU project launches to transform non-clinical research
Lyon, 4/12/2024 --- ETISENSE today announced the launch of NHPig, an EU-funded research project aimed at transforming non clinical safety assessment by use of mini- and micropig models. The goal is to expand and share biological knowledge on mini- and micropig models...
DECRO Solution passed GLP qualification at one CRO !
Preclinical safety, pharmacology and toxicology studies are an essential part of drug development, as they help assess the potential safety and toxicity of a candidate-drug before it is tested in human clinical trials. Good Laboratory Practice (GLP) is a system of...
“Comment la recherche médicale réduit l’expérimentation animale”
"Comment la recherche médicale réduit l’expérimentation animale"Retrouvez Etisense et sa solution non-invasive DECRO dans Le Figaro du 25 août 2023. Les laboratoires sont en quête d'alternatives technologiques, sans pouvoir à ce stade se passer de tests sur les...